Ionis Pharmaceuticals (IONS) Work In Process (2019 - 2025)

Ionis Pharmaceuticals has reported Work In Process for 7 years, with the latest figure at $8.7 million in Q1 2025.

• For the quarter ending Q1 2025, Work In Process rose 44.84% year-over-year to $8.7 million; the trailing twelve-month figure through Mar 2025 stood at $8.7 million (up 44.84% YoY), and the FY2024 full-year result was $6.7 million, up 21.95% from the prior year.
• Work In Process for Q1 2025 stood at $8.7 million, up from $6.7 million in the prior quarter.
• The five-year high for Work In Process was $8.7 million in Q1 2025, with the low at $954000.0 in Q2 2021.
• Average Work In Process over 5 years is $4.4 million, with a median of $3.9 million recorded in 2022.
• Year-over-year, Work In Process sank 72.52% in 2021 and soared 311.64% in 2022.
• Tracing IONS's Work In Process over 5 years: stood at $5.8 million in 2021, then sank by 63.45% to $2.1 million in 2022, then surged by 159.7% to $5.5 million in 2023, then rose by 21.95% to $6.7 million in 2024, then soared by 30.92% to $8.7 million in 2025.
• The last three Work In Process figures came in at $8.7 million (Q1 2025), $6.7 million (Q4 2024), and $6.7 million (Q3 2024), per Business Quant data.

Peer Comparison